Innovation Pharmaceuticals Inc.
SEC CIK 1355250 · ctix · last insider filing 2023-01-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Ehrlich LEO | Director · Chief Financial Officer | filed 2008 - 2023 |
| Spektor Zorik | Director | filed 2016 - 2022 |
| Schechter Barry A | Director | filed 2016 - 2022 |
| Bertolino Arthur Peter | Director · President and CMO | filed 2016 - 2019 |
| Tobin Mark Robert | Director | filed 2016 - 2016 |
| Menon Krishna | Director · President-Chief Scient.Officer | filed 2008 - 2015 |
| Evans George W. | Director · Chief Executive Officer | filed 2008 - 2008 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Harness Jane A. | Vice President | filed 2017 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.